Zacks Investment Research on MSN

Vanda Pharmaceuticals (VNDA) reports Q3 loss, tops revenue estimates

Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to a loss of $0.38 per share a year ago. These ...
The Manila Times

Ligand Reports Third Quarter 2026 Financial Results

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and nine months ended September ...

Travelers Companies Insider Sold Shares Worth $4,332,284, According to a Recent SEC Filing

Learn more Mojgan M Lefebvre, Executive Vice President and Chief Technology & Operations Officer, on October 27, 2026, sold 11,000 shares in Travelers Companies (TRV) for $4,332,284.

Quanterix To Report Third Quarter 2026 Financial Results on November 9, 2026

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that it will host a conference call on Monday, November 9, 2026, at 8:30 AM ET, to discuss its ...
Investing.com France

ALPS Medical Breakthroughs ETF (SBIO)

Informations sur les trackers ETF ALPS Medical Breakthroughs dont le cours, dernier prix: 56,86 de SBIO en bourse.
cj

信诺维第三季度研发投入同比增长38.39% 对外授权收益逐步兑现

本报讯 （记者陈红 见习记者毕凤杰）10月28日晚间，苏州信诺维医药科技股份有限公司（以下简称“信诺维”）披露2026年三季报。公司第三季度实现营业收入5714.80万元，同比下降93.88%；归属于上市公司股东的净利润亏损1.28亿元；归属于上市公司股东的扣除非经常性损益的净利润亏损1.48亿元。
新浪财经

TVTX收跌0.07%，成交额7621.83万美元

10月29日，TVTX（TVTX）收跌0.07%，报50.84美元，成交额7621.83万美元，市值47.93亿美元。行情数据• 开盘价：50.2美元• 最高价：50.91美元• 最低价：49.52美元• 成交量：151.08万股• 换手率：1.6%• 52周 ...